-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BMBjx0ozleqaNaiYweiM19CAhIR7wGNQJe/ecxBklas7yP1zCBEWVUsu+2VITfSA XQm0x4CG6A+Z7/nS6j6/3w== 0001169245-09-000004.txt : 20091112 0001169245-09-000004.hdr.sgml : 20091111 20091112102403 ACCESSION NUMBER: 0001169245-09-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20091112 DATE AS OF CHANGE: 20091112 EFFECTIVENESS DATE: 20091112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PhaseBio Pharmaceuticals Inc CENTRAL INDEX KEY: 0001169245 IRS NUMBER: 030375697 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-40668 FILM NUMBER: 091174933 BUSINESS ADDRESS: STREET 1: 4020 AERIAL CENTER PARKWAY STREET 2: SUITE 101 CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-535-8861 MAIL ADDRESS: STREET 1: 4020 AERIAL CENTER PARKWAY STREET 2: SUITE 101 CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: Phase Biosciences Inc DATE OF NAME CHANGE: 20061013 FORMER COMPANY: FORMER CONFORMED NAME: DT BIOSCIENCES INC DATE OF NAME CHANGE: 20020315 D 1 primary_doc.xml X0603 D LIVE 0001169245 PhaseBio Pharmaceuticals Inc 4020 AERIAL CENTER PARKWAY SUITE 101 MORRISVILLE NC 27560 919-535-8861 DELAWARE Phase Biosciences Inc DT BIOSCIENCES INC Corporation true Christopher Prior 4020 Aerial Center Parkway Suite 101 Morrisville NC 27560 Executive Officer Director Thomas K Laundon 118 Wisteria Drive Chapel Hill NC 27514 Executive Officer Director Ashutosh Chilkoti 1001 Gloria Avenue Durham NC 27701 Director Clay Thorp 208 S. Mangum Street Suite 350 Durham NC 27701 Director Will Shen c/o Johnson & Johnson Development Corp 410 George Street New Brunswick NJ 08901 Director Guy Fish 222 Berkeley Street 20th Floor Boston MA 02116 Director Douglas Reed 280 S. Mangum Street Suite 350 Durham NC 27701 Director Craig Rosen 370 Eagle Hill Road Pasadena MD 21122 Director Biotechnology Decline to Disclose 06 false 2009-11-03 false true false 0 1000000 999999 1 false 6 0 0 0 Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering. false PhaseBio Pharmaceuticals Inc Christopher Prior, Ph.D. Christopher Prior, Ph.D. CEO and President 2009-11-11 -----END PRIVACY-ENHANCED MESSAGE-----